HeraMED Limited (ASX:HMD)
Australia
· Delayed Price · Currency is AUD 0.0160
0.00 (0.00%)
Apr 24, 2025, 3:48 PM AEST
HeraMED Revenue
In the year 2024, HeraMED had annual revenue of 364.33K AUD, down -39.90%. HeraMED had revenue of 183.44K in the half year ending December 31, 2024, with 132.44% growth.
Revenue
364.33K
Revenue Growth
-39.90%
P/S Ratio
38.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 364.33K | -241.90K | -39.90% |
| Dec 31, 2023 | 606.23K | 387.31K | 176.92% |
| Dec 31, 2022 | 218.92K | 132.26K | 152.63% |
| Dec 31, 2021 | 86.65K | 47.14K | 119.29% |
| Dec 31, 2020 | 39.52K | -105.87K | -72.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |